Skip to content

Clinical trials

Phase 2 Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Phase 2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20031
20051
20063
20073
20081
20091
20112
20121
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc4
Bayer1
Boehringer Ingelheim1
Bryan Cotton1
Daiichi Sankyo1
Daiichi Sankyo Co., Ltd.1
GlaxoSmithKline1
Hull University Teaching Hospitals NHS Trust1
Kristen Ban1
Landspitali University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism20
Venous Thromboembolism5
Atrial Fibrillation4
Hemorrhage2
Stroke2
Venous Thrombosis2
Accidental Injuries1
Arterial Occlusive Diseases1
Carcinoma, Ovarian Epithelial1
Embolism and Thrombosis1

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.